egonol profile

egonol : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a methoxy group at position 7, a 1,3-benzodioxol-5-yl group at position 2 and a 3-hydroxypropyl group at position 5. It has been isolated from Styrax agrestis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Related Flora

Flora	Rank	Flora Definition	Family	Family Definition
Styrax	genus	A plant genus of the family STYRACACEAE. Sap of these Asian trees are a source of a balsam (BALSAMS). This styrax balsam is 3/4 coniferyl benzoate, 1/8 free BENZOIC ACID, along with benzyl cinnamate, vanillin, and TRITERPENES.[MeSH]	Styracaceae	A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida.[MeSH]

ID Source	ID
PubMed CID	485186
CHEMBL ID	470981
CHEBI ID	69558
SCHEMBL ID	4183989

Synonym
3-[2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propan-1-ol
5-(3''-hydroxypropyl)-7-methoxy-2-(3',4'-methylenedioxyphenyl)benzofuran
3-(2-benzo[1,3]dioxol-5-yl-7-methoxy-benzofuran-5-yl)-propan-1-ol
2-(1,3-benzodioxol-5-yl)-7-methoxy-5-benzofuranpropanol
530-22-3
5-benzofuranpropanol, 2-(1,3-benzodioxol-5-yl)-7-methoxy-
inchi=1/c19h18o5/c1-21-18-8-12(3-2-6-20)7-14-10-16(24-19(14)18)13-4-5-15-17(9-13)23-11-22-15/h4-5,7-10,20h,2-3,6,11h2,1h
egonol
3-[2-(1,3-benzodioxol-5-yl)-7-methoxy-benzofuran-5-yl]propan-1-ol
CHEMBL470981 ,
chebi:69558 ,
3-(2-(benzo[d][1,3]dioxol-5-yl)-7-methoxybenzofuran-5-yl)propan-1-ol
bdbm50327911
5-(3-hydroxypropyl)-7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran
SCHEMBL4183989
5-benzofuranpropanol, 7-methoxy-2-[3,4-(methylenedioxy)phenyl]-
VOLZBKQSLGCZGC-UHFFFAOYSA-N
3-[2-(1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]-1-propanol #
3-[2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-1-benzofuran-5-yl]propan-1-ol
5-(2-hydroxypropyl)-7-methoxy-2-(3,4-methylenedioxyphenyl)benzofuran
2-(1,3-benzodioxol-5-yl)-7-methoxy-5-benzofuranpropanol, 9ci
Q27137901
DTXSID70967474

Role	Description
plant metabolite	Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Class	Description
1-benzofurans	A member of the class of benzofurans consisting of a 1-benzofuran skeleton and its substituted derivatives thereof.
aromatic ether	Any ether in which the oxygen is attached to at least one aryl substituent.
benzodioxoles
primary alcohol	A primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Fatty acid synthase	Homo sapiens (human)	IC50 (µMol)	91.0700	0.0077	2.4624	5.8000	AID517164
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
osteoblast differentiation	Fatty acid synthase	Homo sapiens (human)
glandular epithelial cell development	Fatty acid synthase	Homo sapiens (human)
fatty acid metabolic process	Fatty acid synthase	Homo sapiens (human)
fatty acid biosynthetic process	Fatty acid synthase	Homo sapiens (human)
inflammatory response	Fatty acid synthase	Homo sapiens (human)
ether lipid biosynthetic process	Fatty acid synthase	Homo sapiens (human)
neutrophil differentiation	Fatty acid synthase	Homo sapiens (human)
monocyte differentiation	Fatty acid synthase	Homo sapiens (human)
mammary gland development	Fatty acid synthase	Homo sapiens (human)
modulation by host of viral process	Fatty acid synthase	Homo sapiens (human)
cellular response to interleukin-4	Fatty acid synthase	Homo sapiens (human)
establishment of endothelial intestinal barrier	Fatty acid synthase	Homo sapiens (human)
fatty-acyl-CoA biosynthetic process	Fatty acid synthase	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
RNA binding	Fatty acid synthase	Homo sapiens (human)
[acyl-carrier-protein] S-acetyltransferase activity	Fatty acid synthase	Homo sapiens (human)
[acyl-carrier-protein] S-malonyltransferase activity	Fatty acid synthase	Homo sapiens (human)
3-oxoacyl-[acyl-carrier-protein] synthase activity	Fatty acid synthase	Homo sapiens (human)
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity	Fatty acid synthase	Homo sapiens (human)
(3R)-3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity	Fatty acid synthase	Homo sapiens (human)
protein binding	Fatty acid synthase	Homo sapiens (human)
(3R)-3-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity	Fatty acid synthase	Homo sapiens (human)
(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity	Fatty acid synthase	Homo sapiens (human)
fatty acyl-[ACP] hydrolase activity	Fatty acid synthase	Homo sapiens (human)
phosphopantetheine binding	Fatty acid synthase	Homo sapiens (human)
cadherin binding	Fatty acid synthase	Homo sapiens (human)
(3R)-3-hydroxybutanoyl-[acyl-carrier-protein] hydratase activity	Fatty acid synthase	Homo sapiens (human)
(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity	Fatty acid synthase	Homo sapiens (human)
enoyl-[acyl-carrier-protein] reductase (NADPH) activity	Fatty acid synthase	Homo sapiens (human)
fatty acid synthase activity	Fatty acid synthase	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
Golgi apparatus	Fatty acid synthase	Homo sapiens (human)
cytosol	Fatty acid synthase	Homo sapiens (human)
plasma membrane	Fatty acid synthase	Homo sapiens (human)
membrane	Fatty acid synthase	Homo sapiens (human)
melanosome	Fatty acid synthase	Homo sapiens (human)
glycogen granule	Fatty acid synthase	Homo sapiens (human)
extracellular exosome	Fatty acid synthase	Homo sapiens (human)
cytoplasm	Fatty acid synthase	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (24)

Assay ID	Title	Year	Journal	Article
AID382878	Antibacterial activity against Bacillus subtilis by Muller Hilton broth method	2008	Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8	Synthesis and antibacterial activity of egonol derivatives.
AID1498471	Cytotoxicity against human CEM/ADR5000 cells over-expressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay	2018	Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12	Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin.
AID1324362	Cytotoxicity against aromatase overexpressing HEK293A cells assessed as effect on cell proliferation at 10 to 50 uM	2016	Bioorganic & medicinal chemistry letters, 11-15, Volume: 26, Issue:22	2-Phenylbenzo[b]furans: Synthesis and promoting activity on estrogen biosynthesis.
AID1076686	Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein by resazurin assay	2014	European journal of medicinal chemistry, Mar-21, Volume: 75	Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells.
AID568137	Antimicrobial activity against Staphylococcus aureus ATCC 29213 by MHB method	2011	Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3	Synthesis of egonol derivatives and their antimicrobial activities.
AID1256625	Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 3 to 30 ug/ml after 24 hrs by Griess reaction	2015	Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22	Inhibitory effects of compounds from Styrax obassia on NO production.
AID399902	Cytotoxicity against human KATO III cells	2004	Journal of natural products, Feb, Volume: 67, Issue:2	Biologically active compounds from Aphyllophorales (polypore) fungi.
AID1076689	Antimalarial activity against Plasmodium falciparum 3D7 assessed as growth inhibition after 3 days by HRP2 based ELISA	2014	European journal of medicinal chemistry, Mar-21, Volume: 75	Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells.
AID382879	Antibacterial activity against Candida albicans by Muller Hilton broth method	2008	Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8	Synthesis and antibacterial activity of egonol derivatives.
AID1498470	Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay	2018	Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12	Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin.
AID1076685	Resistance ratio of IC50 for human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein to IC50 for human CCRF-CEM cells	2014	European journal of medicinal chemistry, Mar-21, Volume: 75	Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells.
AID568139	Antimicrobial activity against Candida albicans ATCC 10231 by MHB method	2011	Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3	Synthesis of egonol derivatives and their antimicrobial activities.
AID623717	Inhibition of electric eel AChE using acetylthiocholine iodide as substrate by spectrophotometric method	2011	Journal of natural products, Oct-28, Volume: 74, Issue:10	Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: structure-activity relationships and molecular modeling studies.
AID1498473	Antiviral activity against GFP-fused Human cytomegalovirus AD169 infected in primary HFF	2018	Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12	Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin.
AID517164	Inhibition of FAS	2010	Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20	Fatty acid synthase inhibitors of phenolic constituents isolated from Garcinia mangostana.
AID382880	Antibacterial activity against Escherichia coli by Muller Hilton broth method	2008	Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8	Synthesis and antibacterial activity of egonol derivatives.
AID568140	Antimicrobial activity against Escherichia coli ATCC 8739 by MHB method	2011	Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3	Synthesis of egonol derivatives and their antimicrobial activities.
AID382877	Antibacterial activity against Staphylococcus aureus by Muller Hilton broth method	2008	Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8	Synthesis and antibacterial activity of egonol derivatives.
AID1076688	Cytotoxicity against human CCRF-CEM cells by resazurin assay	2014	European journal of medicinal chemistry, Mar-21, Volume: 75	Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells.
AID623718	Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate by spectrophotometric method	2011	Journal of natural products, Oct-28, Volume: 74, Issue:10	Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: structure-activity relationships and molecular modeling studies.
AID623719	Inhibition of human serum BChE using butyrylthiocholine iodide as substrate by spectrophotometric method	2011	Journal of natural products, Oct-28, Volume: 74, Issue:10	Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: structure-activity relationships and molecular modeling studies.
AID1498472	Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes after 72 hrs by SYBR green dye fluorescence assay	2018	Bioorganic & medicinal chemistry, 07-23, Volume: 26, Issue:12	Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin.
AID568138	Antimicrobial activity against Bacillus subtilis ATCC 6633 by MHB method	2011	Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3	Synthesis of egonol derivatives and their antimicrobial activities.
AID623720	Inhibition of human recombinant AChE-mediated amyloid beta (1-40) aggregation at 100 uM after 48 hrs by thioflavin T fluorescence assay	2011	Journal of natural products, Oct-28, Volume: 74, Issue:10	Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: structure-activity relationships and molecular modeling studies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (22.22)	29.6817
2010's	7 (77.78)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (11.11%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	8 (88.89%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
chloroquine Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.. chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.	2.17	1	aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug
thymoquinone thymoquinone: constituent of cedarwood; can cause dermatitis; structure. thymoquinone : A member of the class of 1,4-benzoquinones that is 1,4-bezoquinone in which the hydrogens at positions 2 and 5 are replaced by methyl and isopropyl groups, respectively. It is a natural compound isolated from Nigella sativa which has demonstrated promising chemotherapeutic activity.	7.17	1	1,4-benzoquinones	adjuvant; anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; cardioprotective agent; plant metabolite
epigallocatechin gallate epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis). (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.	2.05	1	flavans; gallate ester; polyphenol	antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite
artemisinin (+)-artemisinin : A sesquiterpene lactone obtained from sweet wormwood, Artemisia annua, which is used as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria.	7.17	1	organic peroxide; sesquiterpene lactone	antimalarial; plant metabolite
propidium iodide [no description available]	2.06	1	organic iodide salt
cyclophellitol cyclophellitol: structure given in first source; isolated from Phellinus sp.	3.12	1
homoegonol homoegonol: has anti-asthmatic activity; structure in first source	2.54	2
betulinan a betulinan A: a lipid peroxidation inhibitor; from Lenzites betulina; structure given in first source	3.12	1
(+)-epicatechin (+)-epicatechin : A catechin that is flavan carrying five hydroxy substituents at positions 3, 3', 4', 5 and 7 (the 2S,3S-stereoisomer).	2.05	1	catechin; polyphenol	cyclooxygenase 1 inhibitor; plant metabolite
lariciresinol lariciresinol: found in human urine. (+)-lariciresinol : A lignan that is tetrahydrofuran substituted at positions 2, 3 and 4 by 4-hydroxy-3-methoxyphenyl, hydroxymethyl and 4-hydroxy-3-methoxybenzyl groups respectively (the 2S,3R,4R-diastereomer).	2.11	1	aromatic ether; lignan; oxolanes; phenols; primary alcohol	antifungal agent; plant metabolite
syringaresinol (+)-syringaresinol : The (7alpha,7'alpha,8alpha,8'alpha)-stereoisomer of syringaresinol.	2.11	1	syringaresinol	antineoplastic agent
artenimol [no description available]	2.17	1
epipinoresinol epipinoresinol : An enantiomer of pinoresinol having (+)-(1R,3aR,4S,6aR)-configuration.	2.11	1	pinoresinol	marine metabolite; plant metabolite
tacrine hydrochloride [no description available]	2.06	1
gentisein gentisein: isolated from the methanol extract of the herb of Hypericum annulatum; structure in first source. gentisein : A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3 and 7.	2.05	1	polyphenol; xanthones	plant metabolite
mangostin mangostin: xanthone from rind of Garcinia mangostana Linn. fruit. alpha-mangostin : A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities.	2.05	1	aromatic ether; phenols; xanthones	antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite
norathyriol norathyriol: from Gentinanaceae; has vasorelaxing action on rat thoracic aorta; structure given in first source. norathyriol : A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, 6 and 7. Isolated from Garcinia mangostana and Maclura pomifera, it exhibits inhibitory activity against protein kinase C.	2.05	1	polyphenol; xanthones	antineoplastic agent; EC 2.7.11.13 (protein kinase C) inhibitor; plant metabolite
albaconol albaconol: from the mushroom Albatrellus; structure in first source	3.12	1
gamma-mangostin gamma-mangostin : A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3, 6 and 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antitumour activity.	2.05	1	phenols; xanthones	antineoplastic agent; plant metabolite; protein kinase inhibitor
poricoic acid g poricoic acid G: from Poria cocos (Polyporaceae); structure in first source. poricoic acid G : A tricyclic triterpenoid isolated from Poria cocos.	3.12	1	dicarboxylic acid; secondary alcohol; tricyclic triterpenoid	fungal metabolite
beta-Mangostin [no description available]	2.05	1	xanthones
9-Hydroxycalabaxanthone [no description available]	2.05	1	xanthones
artesunate artesunic acid: RN given for (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,(2aR*))-isomer; succinic ester of artemether	2.53	2	artemisinin derivative; cyclic acetal; dicarboxylic acid monoester; hemisuccinate; semisynthetic derivative; sesquiterpenoid	antimalarial; antineoplastic agent; ferroptosis inducer
hypnophilin hypnophilin: structure in first source	3.12	1	sesquiterpenoid
garcinone e garcinone E: has potent cytotoxic effect against hepatocellular carcinoma cell lines; structure in first source	2.05	1	xanthones
ganciclovir [no description available]	2.17	1	2-aminopurines; oxopurine	antiinfective agent; antiviral drug

Condition	Relationship Strength	Studies
Leucocythaemia [description not available]	2.1	1
Plasmodium falciparum Malaria [description not available]	2.1	1
Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)	7.1	1
Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.	2.1	1
Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.	2.17	1

egonol

Description

Cross-References

Synonyms (23)

Roles (1)

Drug Classes (4)

Protein Targets (1)

Inhibition Measurements

Biological Processes (13)

Molecular Functions (16)

Ceullar Components (8)

Bioassays (24)

Research

Studies (9)

Study Types

egonol

Description

Related Flora

Cross-References

Synonyms (23)

Roles (1)

Drug Classes (4)

Protein Targets (1)

Inhibition Measurements

Biological Processes (13)

Molecular Functions (16)

Ceullar Components (8)

Bioassays (24)

Research

Studies (9)

Study Types

Related Drugs (26)

Related Conditions (5)